Clinical Trial Update: The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a tissue-equivalent cultured-cell product for healing skin blemishes in neurotrophic ulcers and burns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Neurotrophic Ulcers

Drugs mentioned

• Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes (tissue-engineered skin substitute)

Snippet

Sponsor: Ural State Medical University | Conditions: Neurotrophic Ulcers, Burns | Phase 2 | Status: UNKNOWN